Skip to main content
. 2017 Apr 19;50(2):324–334. doi: 10.4143/crt.2016.544

Fig. 2.

Fig. 2.

Crude 5-year overall survival (OS) (A) and disease-specific conditional survival (CS) (B) for patients with nasopharyngeal carcinoma. DSS, disease-specific survival.